文献速递神经肿瘤脊柱脊髓外科

原发性脊髓髓内星形细胞瘤患者总生存时间的个体化预测:一项基于人群的研究

Individualized Prediction of Overall Survival Time for Patients with Primary Intramedullary Spinal Cord Astrocytoma: A Population-Based Study.
PubMed 文献 · World Neurosurg · 2024-11-21

本研究从美国SEER数据库选取1975年至2016年诊断为原发性脊髓髓内星形细胞瘤的582例患者,用Kaplan-Meier法和Cox回归筛选独立预后因素并构建列线图。多因素分析显示肿瘤分级、年龄和手术方式是独立预后因素,模型C指数为0.764,1年、3年、10年生存率AUC分别为0.801、0.842、0.855,校准图和决策曲线显示模型区分度、校准度和临床实用性良好。

要点

  • 肿瘤分级、年龄和手术方式是原发性脊髓髓内星形细胞瘤总生存的独立预后因素。
  • 基于上述因素构建的列线图C指数为0.764,1年、3年、10年生存率AUC分别为0.801、0.842、0.855。
  • 放疗和化疗似乎不改善长期生存,放疗可能使低级别脊髓星形细胞瘤结局更差。

核心结论

  • 较低的世界卫生组织肿瘤分级、较年轻的年龄组和接受全切除术是影响原发性脊髓髓内星形细胞瘤患者预后的显著保护因素。
  • 在II级星形细胞瘤患者中,女性似乎是保护因素,而在III级星形细胞瘤中,男性似乎是保护因素。
  • 放疗和化疗似乎不改善长期生存;具体而言,放疗可能使低级别脊髓星形细胞瘤的结局更差。
  • 研究未发现肿瘤大小、诊断年份、种族或婚姻状况对预后有影响。
  • 研究开发了首个预测原发性脊髓髓内星形细胞瘤患者预后的模型和列线图,显示出良好的预测能力,内部验证表现良好,为临床医生个体化预测患者总生存时间提供了工具。

研究设计与样本

  • 本研究从美国监测、流行病学和最终结果(SEER)数据库中选取1975年至2016年间诊断为原发性脊髓髓内星形细胞瘤的患者,共纳入582例合格患者。
  • 采用Kaplan-Meier法对各种因素进行生存分析以初步筛选潜在预后影响,使用单因素和多因素Cox回归分析识别独立危险因素。
  • 构建多因素Cox回归模型,并使用列线图对模型进行可视化,最后应用多种方法对模型进行验证和评价。

主要发现

  • 多因素Cox分析显示,肿瘤分级、年龄和手术方式是总生存的独立预后因素。
  • 模型总体C指数为0.764,表明具有良好的区分能力。
  • 时间依赖受试者工作特征曲线分析显示模型区分度良好,1年生存率曲线下面积(AUC)为0.801(95%置信区间[CI]:0.763-0.839),3年生存率AUC为0.842(95%CI:0.809-0.874),10年生存率AUC为0.855(95%CI:0.821-0.888)。
  • 校准图也显示模型校准良好,决策曲线分析表明列线图在预测1年、3年和10年总生存方面具有良好的临床实用性。
  • 基于增强bootstrap重抽样的内部验证显示列线图预测与实际观察之间具有良好的一致性。

关键数值与推荐

  • 较低的世界卫生组织肿瘤分级、较年轻的年龄组和接受全切除术是显著保护因素。
  • 在II级星形细胞瘤患者中,女性似乎是保护因素;在III级星形细胞瘤中,男性似乎是保护因素。
  • 放疗和化疗似乎不改善长期生存;放疗可能使低级别脊髓星形细胞瘤的结局更差。
  • 肿瘤大小、诊断年份、种族或婚姻状况对预后无影响。
  • 模型总体C指数为0.764,1年、3年、10年生存率AUC分别为0.801(95%CI:0.763-0.839)、0.842(95%CI:0.809-0.874)、0.855(95%CI:0.821-0.888)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence rate of primary intramedullary spinal cord astrocytoma (IMSCA) is approximately 0.047 per 100,000 individuals per year, making it the second most common type of intramedullary spinal cord tumor. Due to its rarity, there is a scarcity of related research, and prognostic factors remain unclear. The aim of this study is to identify risk factors affecting the prognosis of patients with primary IMSCA. Based on these factors, we aim to develop and visualize a prognostic model for predicting the overall survival time of patients with this condition, thereby facilitating individualized predictions of overall survival time for patients with primary IMSCA. METHODS: This study selected patients diagnosed with primary IMSCA between 1975 and 2016 from the United States Surveillance, Epidemiology, and End Results database, incorporating a total of 582 eligible patients. We employed the Kaplan-Meier method for survival analysis of various factors to preliminary screen for potential prognostic influences. Univariate and multivariate Cox regression analyses were utilized to identify independent risk factors. A multivariate Cox regression model was constructed, and the model was visualized using a nomogram. Finally, various methods were applied to validate and evaluate the model. RESULTS: Multivariate Cox analysis revealed that tumor grade, age, and surgical approach are independent prognostic factors for overall survival. A multivariate Cox regression model and a nomogram were developed based on these factors. The overall C-index of the model was 0.764, indicating good discriminative ability. Time-dependent receiver operating characteristic curve analysis showed the model had a good distinction with a 1-year survival rate area under the curve (AUC) of 0.801 (95% confidence interval [CI]: 0.763-0.839), a 3-year survival rate AUC of 0.842 (95% CI: 0.809-0.874), and a 10-year survival rate AUC of 0.855 (95% CI: 0.821-0.888). Calibration plots also demonstrated good model calibration. Decision curve analysis indicated that the nomogram had good clinical utility in predicting 1-year, 3-year, and 10-year overall survival. Internal validation based on enhanced bootstrap resampling showed good consistency between nomogram predictions and actual observations. CONCLUSIONS: Lower World Health Organization's tumor grade, younger age groups, and undergoing gross total resection surgery are significant protective factors affecting the prognosis of patients with primary IMSCA. Among patients with Grade II astrocytoma, being female appears to be a protective factor, whereas being male seems to be a protective factor in Grade III astrocytoma. Radiation therapy and chemotherapy do not appear to improve long-term survival; specifically, radiation therapy may lead to worse outcomes for low-grade spinal cord astrocytomas. The study found no impact of tumor size, year of diagnosis, race, or marital status on prognosis. We have developed the first model and nomogram to predict the prognosis of patients with primary IMSCA, which demonstrates good predictive ability. The nomogram performed well in internal validation, offering a tool to help clinicians predict the overall survival time of patients with primary IMSCA on an individual basis.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Li Y, Zheng Z, He Q, et al. Individualized Prediction of Overall Survival Time for Patients with Primary Intramedullary Spinal Cord Astrocytoma: A Population-Based Study. World Neurosurg. 2024. PMID: 39510174. doi:10.1016/j.wneu.2024.10.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。